Prof Jean Louis Abdourahim Ndiaye, OPT-SMC project PI in Senegal

Prof Jean Louis Abdourahim Ndiaye, in charge of Monitoring and Evaluation in MARCAD, has been selected to lead the Opt-SMC project, which aims to optimize the delivery and effectiveness of Seasonal Malaria Chemoprevention (SMC).

In the Sahel and sub-Saharan regions of Africa, malaria-related death and serious illness occur mainly among young children during the rainy season, which generally lasts three to five months. SMC helps to ensure a high level of protection against malaria in children during that period.
SMC consists of monthly administration of sulfadoxine-pyrimethamine and amodiaquine to children from three months to five years during the peak of malaria transmission season. In Senegal, the target has been extended to children up to 10 years old.
The Opt-SMC project is a partnership between the University of Thiès in Senegal, the UNDP/UNICEF/World Bank/WHO Special Programme for Research and Training in Tropical Diseases (TDR), Medicines for Malaria Venture (MMV) and the London School of Hygiene and Tropical Medicine (LSHTM).

The project is funded by the European and Developing Countries Clinical Trials Partnership (EDCTP). Its main objective is to strengthen capacities of the National Malaria Control Programmes in 13 countries, Benin, Burkina Faso, Cameroun, Chad, The Gambia, Ghana, Guinea, Guinea Bissau, Mali, Niger, Nigeria, Senegal, Togo.
In addition, the project aims to develop tools for planning, monitoring, implementation research and impact evaluation of SMC deployment, as well as to promote collaboration and information and expertise sharing between countries.
About Prof Jean Louis A. Ndiaye : http://www.marcad-africa.org/index.php/who-we-are/secretariat/427-monitoring-evaluation-officer